Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Receivables: 2009-2024

Historic Change in Receivables for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $1.9 million.

  • Cumberland Pharmaceuticals' Change in Receivables rose 136.78% to $113,691 in Q3 2025 from the same period last year, while for Sep 2025 it was -$880,023, marking a year-over-year increase of 8.53%. This contributed to the annual value of $1.9 million for FY2024, which is 157.07% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Change in Receivables stood at $1.9 million for FY2024, which was up 157.07% from -$3.4 million recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Change in Receivables peaked at $6.1 million during FY2022, and registered a low of -$5.5 million during FY2021.
  • In the last 3 years, Cumberland Pharmaceuticals' Change in Receivables had a median value of $1.9 million in 2024 and averaged $1.6 million.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Change in Receivables soared by 222.99% in 2020 and then plummeted by 221.72% in 2021.
  • Cumberland Pharmaceuticals' Change in Receivables (Yearly) stood at $4.5 million in 2020, then tumbled by 221.72% to -$5.5 million in 2021, then surged by 211.19% to $6.1 million in 2022, then plummeted by 155.68% to -$3.4 million in 2023, then soared by 157.07% to $1.9 million in 2024.